Functional dyspepsia. Functional dyspepsia
Conditions
Interventions
Intervention 1: Intervention group 1 patients who are given sertraline 50 mg daily (Abidi Pharmaceutical Company made in Iran) + PPI drugs for three month. Intervention 2: Intervention group 2 patient
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Willingness to participate in the study after fully explaining the objectives of the research and the disadvantages and advantages of the methods not receiving psychological therapies before entering the study No alcohol and drugs Absence of danger signs such as gastrointestinal bleeding, blood in the stool, fever, weight loss, anemia, nocturnal diarrhea, severe heartburn No psychotic disorder and personality disorder Possibility to keep the type and amount of drug used during the research period if the drug is used No other organic disease Lack of other structural or functional gastrointestinal disorders
Exclusion criteria
Exclusion criteria: Having psychotic disorder or other gastrointestinal disorders Existence of danger signs in the patient (such as gastrointestinal bleeding, blood in the stool, fever, weight loss, anemia, nocturnal diarrhea, severe heartburn, etc.) Having complete criteria for personality disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety score in Beck questionnaire. Timepoint: at the beggining (day 0),day 30,day 90. Method of measurement: Beck anxiety questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Upper gastrointestinal symptoms severity questionnaire PAGI-SYM. Timepoint: At the beggining (day 0), day 30, day 90. Method of measurement: 20-item PAGI-SYM symptom severity questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHajar Rahmani Firoozjaee
Birjand University of Medical Sciences
Outcome results
None listed